Vijay Sangar
Overview
Explore the profile of Vijay Sangar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bola B, Hoskin P, Sangar V, Choudhury A
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002223
Global shortages, toxicities, and high levels of incomplete treatment with Bacillus Calmette Guerin (BCG) for non-muscle invasive bladder cancer has resulted in increasing interest in alternative treatments. Radiotherapy is not...
2.
Pang K, Fallara G, Lobo J, Alnajjar H, Sangar V, von Stempel C, et al.
Eur Urol Oncol
. 2024 Nov;
8(1):152-163.
PMID: 39500644
Background And Objective: The majority of small testicular masses (STMs) are benign and therefore radical orchidectomy (RO) may represent overtreatment. In appropriately selected patients, surveillance or testis-sparing surgery (TSS) is...
3.
Adegboye O, Churchill J, Moorjani J, Johnson H, Capper S, Booker J, et al.
Clin Genitourin Cancer
. 2024 Aug;
22(5):102168.
PMID: 39117530
Background: Penile cancer (PeCa) is a rare cancer with surgical options that affect patients' quality-of-life. Patient-reported outcome measures (PROMs) are uncommonly utilized in this cohort despite their several patient-centered benefits...
4.
Tang S, Akers C, Alnajjar H, Ayres B, Baldini C, Embleton-Thirsk A, et al.
Pilot Feasibility Stud
. 2024 Apr;
10(1):61.
PMID: 38600541
Background: Penile cancer is a rare male genital malignancy. Surgical excision of the primary tumour is followed by radical inguinal lymphadenectomy if there is metastatic disease detected by biopsy, fine...
5.
Han L, Sullivan R, Tree A, Lewis D, Price P, Sangar V, et al.
Radiother Oncol
. 2024 Jan;
192:110092.
PMID: 38219910
Background: The distances that patients have to travel can influence their access to cancer treatment. We investigated the determinants of travel time, separately for journeys by car and public transport,...
6.
Elst L, Vreeburg M, de Vries H, Vandermaesen K, Murphy T, Churchill J, et al.
Eur Urol Oncol
. 2023 Oct;
7(3):478-484.
PMID: 37813746
Background: Penile squamous cell carcinoma (PSCC) is characterised by stepwise lymphatic dissemination. Skip metastases (SkMs) are rare metastases in the corpus cavernosum or spongiosum without continuity to the primary tumour...
7.
Lee E, Antonelli L, Issa A, Churchill J, Sachdeva A, Oliveira P, et al.
J Urol
. 2023 Sep;
210(5):778-781.
PMID: 37675864
Purpose: Up to 90% of men with a positive surgical margin show remaining cancer in subsequent reresections. The risk of local recurrence in men with no penile cancer but the...
8.
Aggarwal A, Han L, Sullivan R, Haire K, Sangar V, van der Meulen J
Lancet Reg Health Eur
. 2023 Jul;
30:100642.
PMID: 37465324
Background: Waiting times for cancer treatments continue to increase in many countries. In this study we estimated potential 'spare surgical capacity' in the English NHS and identified regions more likely...
9.
Schifano N, Fallara G, Rezvani S, Pozzi E, Churchill J, Castiglione F, et al.
World J Urol
. 2023 Apr;
41(6):1581-1588.
PMID: 37019998
Purpose: To describe our surgical technique and report the oncological outcomes and complication rates using a fascial-sparing radical inguinal lymphadenectomy (RILND) technique for penile cancer patients with cN+ disease in...
10.
Maitre P, Sangar V, Choudhury A
Eur Urol
. 2023 Mar;
83(6):495-496.
PMID: 36898871
No abstract available.